DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65

Cell Death Dis. 2021 Jul 17;12(8):715. doi: 10.1038/s41419-021-04002-1.

Abstract

Parkinson's disease (PD), one of the most common neurodegenerative disorders, is characterized by progressive neurodegeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). DJ-1 acts essential roles in neuronal protection and anti-neuroinflammatory response, and its loss of function is tightly associated with a familial recessive form of PD. However, the molecular mechanism of DJ-1 involved in neuroinflammation is largely unclear. Here, we found that wild-type DJ-1, rather than the pathogenic L166P mutant DJ-1, directly binds to the subunit p65 of nuclear factor-κB (NF-κB) in the cytoplasm, and loss of DJ-1 promotes p65 nuclear translocation by facilitating the dissociation between p65 and NF-κB inhibitor α (IκBα). DJ-1 knockout (DJ-1-/-) mice exhibit more microglial activation compared with wild-type littermate controls, especially in response to lipopolysaccharide (LPS) treatment. In cellular models, knockdown of DJ-1 significantly upregulates the gene expression and increases the release of LPS-treated inflammatory cytokines in primary microglia and BV2 cells. Furthermore, DJ-1 deficiency in microglia significantly enhances the neuronal toxicity in response to LPS stimulus. In addition, pharmacological blockage of NF-κB nuclear translocation by SN-50 prevents microglial activation and alleviates the damage of DA neurons induced by microglial DJ-1 deficiency in vivo and in vitro. Thus, our data illustrate a novel mechanism by which DJ-1 facilitates the interaction between IκBα and p65 by binding to p65 in microglia, and thus repressing microglial activation and exhibiting the protection of DA neurons from neuroinflammation-mediated injury in PD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Dopaminergic Neurons / drug effects
  • Dopaminergic Neurons / metabolism*
  • HEK293 Cells
  • Humans
  • Inflammation / pathology
  • Lipopolysaccharides
  • Mice
  • Microglia / drug effects
  • Microglia / metabolism*
  • Models, Biological
  • Mutation / genetics
  • Neuroprotective Agents / metabolism*
  • Neurotoxins / toxicity
  • Protein Binding / drug effects
  • Protein Deglycase DJ-1 / deficiency
  • Protein Deglycase DJ-1 / genetics
  • Protein Deglycase DJ-1 / metabolism*
  • Protein Subunits / metabolism
  • Protein Transport / drug effects
  • Transcription Factor RelA / metabolism*
  • Transcription, Genetic / drug effects

Substances

  • Lipopolysaccharides
  • Neuroprotective Agents
  • Neurotoxins
  • Protein Subunits
  • Transcription Factor RelA
  • PARK7 protein, mouse
  • Protein Deglycase DJ-1